Phase 2 Breast Cancer Trial, Not Yet Recruiting NCT07080619 Sponsor: Tianjin ConjuStar Biologics Co., Ltd. Condition: Breast Cancer
Back to Breast Cancer

Phase 2 Breast Cancer Trial, Not Yet Recruiting

NCT07080619
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between 18 and 75 years old (inclusive), of any gender.
  • People with a good general health and activity level, rated 0 or 1 on a standard medical scale used to measure how much a condition affects daily activities (confirm with trial site).
  • People whose doctor estimates they are expected to live for more than 3 months.
  • People who are capable of having children must agree to use contraception during the trial.
  • People who are able to understand what the trial involves and are willing and able to follow all trial procedures and attend follow-up appointments.
  • People with healthy enough bone marrow, liver, kidneys, and other organs to safely participate (confirm with trial site).
  • People whose tumour tests positive for a specific gene change called NECTIN-4 amplification.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have central nervous system tumours (such as brain tumours) that are not stable.
  • People who still have significant side effects from previous cancer treatments that have not sufficiently resolved (confirm with trial site).
  • People who have a history of serious heart or blood vessel disease, or serious disease affecting the brain's blood supply.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026

Contact this trial

Phone: 021-33670866

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Tianjin ConjuStar Biologics Co., Ltd.
Registry
ClinicalTrials.gov
Start date
20 September 2025
Est. completion
30 July 2027

Primary endpoints

cORR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov